ÂÜÀòÂÒÂ×

Dany Morisset is an accomplished professional with extensive experience in biotechnology, regulatory affairs, and business management. Currently serving as President of Global Strategic Portfolio - Intestinal Health at Kemin Industries since August 2015, Dany leads initiatives to enhance business growth across various geographies. Prior roles include Director of Quality, Intellectual Property and Regulatory Affairs for Kemin EMENA, and QC Manager for CropDesign, where Dany managed compliance and quality control operations. Dany's career includes roles as R&D Senior Researcher at CO BIK, Project Manager at the National Institute of Biology, and Postdoctoral Researcher at Université Laval. Dany holds an MBA from Antwerp Management School and advanced degrees in biotechnology, biochemistry, and molecular biology from Université Laval and Université de Poitiers.